These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 267281

  • 21. Chronic myeloid leukaemia in Zambians.
    Lowenthal MN.
    Trop Geogr Med; 1975 Jun; 27(2):132-6. PubMed ID: 1058559
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
    Sánchez Fayos J, Outeiriño J, de Villalobos E, Valera M, Alonso M, Calabuig MT, Paniagua G.
    Sangre (Barc); 1981 Jun; 26(1):65-71. PubMed ID: 6942520
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of high dose busulphan on leukaemic progenitor cells in chronic myeloid leukaemia.
    Morstyn G, Sullivan J, Fairhead S, Cowling D, Hurley T.
    Aust N Z J Med; 1981 Dec; 11(6):609-14. PubMed ID: 6949537
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Chronic sialadenitis. A toxic effect of prolonged busulfan therapy for chronic myelogenous leukaemia (author's transl)].
    Morales Polanco MR, Butron L, Echegoyen G, Pizzuto Chavez J.
    Sangre (Barc); 1977 Dec; 22(2):243-51. PubMed ID: 266289
    [No Abstract] [Full Text] [Related]

  • 31. Neutrophil function in chronic granulocytic leukaemia before and after busulphan treatment.
    Whittaker JA, Khurshid M, Hughes HR.
    Br J Haematol; 1974 Dec; 28(4):541-9. PubMed ID: 4616717
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Chromosome aberrations in busulphan therapy (author's transl)].
    Gebhart E, Schwanitz G, Hartwich G.
    Dtsch Med Wochenschr; 1974 Jan 11; 99(2):52-56. PubMed ID: 4520646
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Diabetes insipidus in chronic myeloid leukemia. Remission of hypophyseal infiltration during busulfan treatment].
    Eichhorn P, Rhyner K, Haller D, Hämmerli R, Steuli R, Furrer J.
    Schweiz Med Wochenschr; 1988 Feb 27; 118(8):275-9. PubMed ID: 3162777
    [Abstract] [Full Text] [Related]

  • 37. Case record: Rhode Island Hospital.
    R I Med J (1976); 1983 Mar 27; 66(3):103-8. PubMed ID: 6573014
    [No Abstract] [Full Text] [Related]

  • 38. Busulphan lung.
    Woodliff HJ, Finlay-Jones LR.
    Med J Aust; 1972 Sep 23; 2(13):719-22. PubMed ID: 4507947
    [No Abstract] [Full Text] [Related]

  • 39. Acute leukaemia after busulphan.
    Stott H, Fox W, Girling DJ, Stephens RJ, Galton DA.
    Br Med J; 1977 Dec 10; 2(6101):1513-7. PubMed ID: 589308
    [Abstract] [Full Text] [Related]

  • 40. Pyoderma gangrenosum with chronic myeloid leukaemia.
    Goldin D.
    Proc R Soc Med; 1974 Dec 10; 67(12 Pt 1):1239-40. PubMed ID: 4532236
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.